Ipsen SA (IPN) - Total Assets

Latest as of June 2025: €6.83 Billion EUR ≈ $7.99 Billion USD

Based on the latest financial reports, Ipsen SA (IPN) holds total assets worth €6.83 Billion EUR (≈ $7.99 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore IPN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Ipsen SA - Total Assets Trend (2002–2024)

This chart illustrates how Ipsen SA's total assets have evolved over time, based on quarterly financial data. See net assets of Ipsen SA for net asset value and shareholders' equity analysis.

Ipsen SA - Asset Composition Analysis

Current Asset Composition (December 2024)

Ipsen SA's total assets of €6.83 Billion consist of 31.4% current assets and 68.6% non-current assets.

Asset Category	Amount (EUR)	% of Total Assets
Cash & Equivalents	€0.00	10.5%
Accounts Receivable	€697.20 Million	10.8%
Inventory	€285.50 Million	4.4%
Property, Plant & Equipment	€0.00	0.0%
Intangible Assets	€2.52 Billion	39.1%
Goodwill	€699.50 Million	10.9%

Asset Composition Trend (2002–2024)

This chart illustrates how Ipsen SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Ipsen SA worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Ipsen SA's current assets represent 31.4% of total assets in 2024, an increase from 0.0% in 2002.
Cash Position: Cash and equivalents constituted 10.5% of total assets in 2024, up from 0.2% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 42.0% in 2002.
Asset Diversification: The largest asset category is intangible assets at 39.1% of total assets.

Ipsen SA Competitors by Total Assets

Key competitors of Ipsen SA based on total assets are shown below.

Company	Country	Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	China	CN¥12.75 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.84 Billion
Tasly Pharmaceutical Group Co Ltd SHG:600535	China	CN¥15.69 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	China	CN¥10.21 Billion
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	China	CN¥6.39 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	China	CN¥4.44 Billion
Changzhou Qianhong Biopharma Co Ltd SHE:002550	China	CN¥3.23 Billion

Ipsen SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.98	1.14	1.06
Quick Ratio	1.79	0.98	0.89
Cash Ratio	1.02	0.29	0.00
Working Capital	€1.40 Billion	€234.60 Million	€76.00 Million

Ipsen SA - Advanced Valuation Insights

This section examines the relationship between Ipsen SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.47
Latest Market Cap to Assets Ratio	1.63
Asset Growth Rate (YoY)	1.8%
Total Assets	€6.44 Billion
Market Capitalization	$10.50 Billion USD

Valuation Analysis

Above Book Valuation: The market values Ipsen SA's assets above their book value (1.63x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Ipsen SA's assets grew by 1.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Ipsen SA (2002–2024)

The table below shows the annual total assets of Ipsen SA from 2002 to 2024.

Year	Total Assets	Change
2024-12-31	€6.44 Billion ≈ $7.53 Billion	+1.84%
2023-12-31	€6.32 Billion ≈ $7.39 Billion	+12.75%
2022-12-31	€5.61 Billion ≈ $6.56 Billion	+12.37%
2021-12-31	€4.99 Billion ≈ $5.83 Billion	+15.71%
2020-12-31	€4.31 Billion ≈ $5.04 Billion	+0.14%
2019-12-31	€4.31 Billion ≈ $5.04 Billion	+27.52%
2018-12-31	€3.38 Billion ≈ $3.95 Billion	+9.94%
2017-12-31	€3.07 Billion ≈ $3.59 Billion	+26.76%
2016-12-31	€2.42 Billion ≈ $2.83 Billion	+25.05%
2015-12-31	€1.94 Billion ≈ $2.27 Billion	+13.12%
2014-12-31	€1.71 Billion ≈ $2.00 Billion	+9.46%
2013-12-31	€1.57 Billion ≈ $1.83 Billion	+0.27%
2012-12-31	€1.56 Billion ≈ $1.83 Billion	-4.43%
2011-12-31	€1.63 Billion ≈ $1.91 Billion	-2.67%
2010-12-31	€1.68 Billion ≈ $1.96 Billion	+6.43%
2009-12-31	€1.58 Billion ≈ $1.84 Billion	+0.45%
2008-12-31	€1.57 Billion ≈ $1.84 Billion	+18.66%
2007-12-31	€1.32 Billion ≈ $1.55 Billion	+8.95%
2006-12-31	€1.21 Billion ≈ $1.42 Billion	+28.83%
2005-12-31	€942.51 Million ≈ $1.10 Billion	+52.09%
2004-12-31	€619.71 Million ≈ $724.51 Million	-6.94%
2003-12-31	€665.90 Million ≈ $778.50 Million	+0.54%
2002-12-31	€662.33 Million ≈ $774.34 Million	--

About Ipsen SA

PA:IPN France Drug Manufacturers - Specialty & Generic

Market Cap

$16.10 Billion

€13.78 Billion EUR

Market Cap Rank

#2141 Global

#43 in France

Share Price

€167.20

Change (1 day)

+6.36%

52-Week Range

€105.30 - €172.90

All Time High

€172.90